Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Background: In pancreatic ductal adenocarcinoma (PDAC), the characterization of circulating tumor cells (CTCs) opens new insights into cancer metastasis as the leading cause of cancer-related death. Here, we focused on the expression of retinoic acid receptor responder 1 (RARRES1) on CTCs as a novel...

Full description

Bibliographic Details
Main Authors: Christine Nitschke, Benedikt Markmann, Marie Tölle, Jolanthe Kropidlowski, Yassine Belloum, Mara R. Goetz, Hartmut Schlüter, Marcel Kwiatkowski, Marianne Sinn, Jakob Izbicki, Klaus Pantel, Cenap Güngör, Faik G. Uzunoglu, Harriet Wikman
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
liquid biopsy
circulating tumor cells
RARRES1
pancreatic ductal adenocarcinoma
biomarker
Online Access:https://www.mdpi.com/2072-6694/14/18/4405

Internet

https://www.mdpi.com/2072-6694/14/18/4405

Similar Items